Poster presented at AASLD: The liver meeting 2019 conference | Nov 8-12, 2019 |Boston (USA).

The diagnosis of hepatic fibrosis within liver disease is important for prognosis, stratification for treatment and monitoring of treatment. Although liver biopsy is considered the gold standard for staging fibrosis, it has its limitations due to its invasive nature, sampling error and inter-observer variability. Previous studies have shown that computer tomography (CT) perfusion imaging and splenic radiomics can accurately assess and grade liver fibrosis.